SBFM FY 2017 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$6,629

Operating Income

-$857,190

Net Income

-$1M

EPS (Diluted)

$-23.84

Cash Flow

Operating Cash Flow

-$543,520

Free Cash Flow

-$547,238

Stock-Based Comp.

$427,400

Balance Sheet

Total Assets

$257,485

Total Liabilities

$830,848

Stockholders' Equity

-$573,363

Cash & Equivalents

$107,532

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,629	-$60,731	+89.1%
Operating Income	-$857,190	-$993,108	+13.7%
Net Income	-$1M	-$3M	+70.3%